Tenaya Therapeutics TNYA
NASDAQ TNYA
$0.57 -0.04 (-6.28%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tenaya Therapeutics (TNYA) Research & Development (2020 - 2026)

Updated

Tenaya Therapeutics (TNYA) posted Research & Development of $16.6 million for Q2 2026, down 4.4% from $17.37 million a year earlier but up 11.9% from the prior quarter.

Analysis

Tenaya Therapeutics (TNYA) Research & Development (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Research & Development at Tenaya Therapeutics was $61.61 million, down 20.5% year-over-year; for FY2025, it came in at $68.61 million, down 20.9% from FY2024.

  • Annual Research & Development shows a five-year compound annual growth rate of 17.1% (FY2020 to FY2025).
  • In prior years, Tenaya Therapeutics' Research & Development was $86.74 million in FY2024 (-11.5%), $98.04 million in FY2023 (+3.7%), $94.54 million in FY2022 (+73.8%) and $54.39 million in FY2021 (+74.9%).
  • Quarterly Research & Development has run from a low of $12.94 million in Q3 2021 to a high of $26.48 million in Q2 2023 over five years.
  • On a year-over-year basis, Research & Development has declined in each of the last 12 quarters, with an average decline of 18.6% over the last eight quarters.
  • The strongest year-over-year quarter for Research & Development in the past five years was Q1 2022, with growth of 151.9%; the weakest was Q1 2026, with a decline of 29.6%.
  • According to Business Quant data, Research & Development for the three prior quarters was $14.84 million (Q1 2026), $14.8 million (Q4 2025) and $15.36 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 3.65 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.34 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -4.05 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.76 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 993.80 Mn
10 Tenaya Therapeutics 134.54 Mn 134.54 Mn - 16.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.60 Mn
Mar 31, 2026 14.84 Mn
Dec 31, 2025 14.80 Mn
Sep 30, 2025 15.36 Mn
Jun 30, 2025 17.37 Mn
Mar 31, 2025 21.08 Mn
Dec 31, 2024 18.69 Mn
Sep 30, 2024 20.35 Mn
Jun 30, 2024 22.65 Mn
Mar 31, 2024 25.06 Mn
Dec 31, 2023 22.87 Mn
Sep 30, 2023 23.09 Mn
Jun 30, 2023 26.48 Mn
Mar 31, 2023 25.61 Mn
Dec 31, 2022 25.75 Mn
Sep 30, 2022 23.76 Mn
Jun 30, 2022 20.88 Mn
Mar 31, 2022 24.16 Mn
Dec 31, 2021 20.95 Mn
Sep 30, 2021 12.94 Mn
API Access

Tenaya Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=TNYA&period=max&api_key=YOUR_API_KEY